Volume 9, Issue 4

Managing HIV Coinfections: HBV and TB

In this issue:

Current ART regimens can successfully manage HIV infection in nearly all PLWH. But what happens when a patient with HIV is coinfected with a dangerous pathogen ART alone cannot handle? Two of the most common are hepatitis B and latent tuberculosis infection.

How does ART selection and dosing need to change? Which agents should be avoided? What can a clinician do to get a patient to accept TPT — TB preventive therapy — for a disease that’s currently without symptoms?

Join Drs. Sonya Krishnan and Zachary Lorenz from the Johns Hopkins School of Medicine as we discuss the special needs of managing PLWH with coinfections — in this issue of eHIV Review. 

Learning objective:

Evaluate optimal regimens for patients living with HIV and comorbid infections such as hepatitis B and TB.


Sonya Krishnan, MD, MHS
Sonya Krishnan, MD, MHS

Associate Professor, Infectious Diseases Fellowship Program
Assistant Professor of Medicine
Johns Hopkins Medicine
Baltimore, MD

Zachary W. Lorenz, MD
Zachary W. Lorenz, MD

Infectious Diseases Fellow
Johns Hopkins University School of Medicine
Baltimore, MD

Program Directors:

Justin Alves, RN, FNP-BC, ACRN, CARN, CNE

Nurse Educator
Boston Medical Center
Boston, MA

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: June 20, 2024
Expiration date: June 19, 2026